Nancy Pelosi, one of the most influential figures in modern American politics, is facing mounting challenges on multiple fronts. As she recovers from a recent hip replacement surgery, questions have arisen about her ability to continue serving in Congress. At the same time, she faces a potential primary challenge from progressive leader Saikat Chakrabarti — former chief of staff to Representative Alexandria Ocasio-Cortez — and renewed scrutiny over her husband Paul Pelosi’s high-profile stock trades.

Chakrabarti’s entry into the race signals growing impatience within the Democratic Party’s progressive wing. Known for his work on the Green New Deal and his criticism of establishment Democrats, he’s calling for bold policy shifts and new leadership. Pelosi — who has not yet confirmed if she will seek reelection in 2026 — must now navigate this internal divide while focusing on her recovery. Her age and recent surgery have become central talking points, with both supporters and critics debating her long-term viability in Congress.

Adding to the pressure, Paul Pelosi’s recent $38 million in stock trades — including transactions in Apple, Nvidia, and Tempus AI — have once again drawn accusations of insider influence. Though Pelosi herself has voiced support for a potential congressional stock-trading ban, critics argue that the Pelosi family’s investments highlight why such reform is urgently needed. The controversy has renewed bipartisan calls to prohibit members of Congress and their spouses from trading individual stocks altogether.

Now at a critical crossroads, Pelosi faces a defining choice: mount one more campaign in the face of rising dissent and public scrutiny or step aside after decades of leadership. Her decision will shape not only her legacy but the Democratic Party’s future direction as it balances establishment experience with progressive momentum.